On April 12, 2023, ASTHO released a statement applauding the Office of National Drug Control Policy’s announcement designating fentanyl adulterated or associated with xylazine as an emerging drug threat to the United States.
ASTHO Statement on Rise in National Sexually Transmitted Disease Rates ARLINGTON, VA—Michael Fraser, CEO of the Association of State and Territorial Health Officials (ASTHO), issued the following statement in response to new preliminary ...
ASTHO Celebrates National Public Health Week ASTHO Celebrates National Public Health Week 2017 ARLINGTON, VA—The Association of State and Territorial Health Officials (ASTHO) joins the American Public Health Association (APHA) to observe ...
In honor of ASTHO’s 80th anniversary, a leadership panel—including CEO Michael Fraser, President Anne Zink, Past President Nirav Shah, and Idaho Commissioner of Health Elke Shaw-Tulloch—discusses the unique role ASTHO plays in the public ...
ASTHO and the American Public Human Services Association (APHSA) have partnered to support the transformation of the child welfare system through a prevention-first model. In this episode, ASTHO’s CEO Michael Fraser, along with APHSA’s CEO ...
Every year on Nov. 22, ASTHO—and countless other agencies and organizations worldwide—take a moment to acknowledge the public health workforce on Public Health Thank You Day. Like so many other days of recognition, it has become a blip on ...
On May 16, 2023, ASTHO announced that the annual Public Health TechXpo and Futures Forum in-person registration is sold out. However, virtual participation is still open and encouraged.
On Nov. 2, 2022, ASTHO announced the launch of PublicHealthCareers.com, a new website for job seekers in the field.
ASTHO CEO Michael Fraser's Testimony in Regards to the U.S. Department of Health and Human Services for the Committee on Appropriations, United States Senate